Market research
TLIK.F TELES Aktiengesellschaft Informationstechnologien
F EUR Healthcare
Latest close
Loading market data…
Test a moving-average rule with historical data.
Market facts
- Market cap
- 810K
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 44.47
Profile
Company facts
- Exchange
- F
- Currency
- EUR
- Sector
- Healthcare
- Industry
- Medical Distribution
- ISIN
- DE000A289B07
- Market cap
- 810K
- P/E ratio
- Not available
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 44.47
About
About TELES Aktiengesellschaft Informationstechnologien
Arzneiwerk AG VIDA supplies pharmaceuticals for newly developed or rare medicines in Europe. It also provides medications for cancer, autoimmune deficiencies, and combination therapies of personalized medicine. In addition, the company is involved in operating pharmacy data center that focuses on health data analysis. The company was formerly known as TELES Aktiengesellschaft and changed its name to Arzneiwerk AG VIDA in July 2024. The company was incorporated in 1996 and is based in Berlin, Germany.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the TLIK.F discussion.
5 years, 5 months ago
TELES Aktiengesellschaft Informationstechnologien is currently in a long term uptrend where the price is trading 7.6% above its 200 day moving average.
From a valuation standpoint, the stock is 86.1% cheaper than other stocks from the Technology sector with a price to sales ratio of 1.9.
TELES Aktiengesellschaft Informationstechnologien's total revenue rose by 64.4% to $577K since the same quarter in the previous year.
Its net income has dropped by 125.8% to $-207K since the same quarter in the previous year.
Finally, its free cash flow fell by 86.9% to $-555K since the same quarter in the previous year.
Based on the above factors, TELES Aktiengesellschaft Informationstechnologien gets an overall score of 3/5.